During the 13th five year plan, Hainan will speed up the research and development of Nanyao Liyao's marine drugs

[policies and regulations of chinapharma.com] it is understood that during the 13th Five Year Plan period, Hainan will speed up the research and development of Nanyao and Liyao marine drugs, and the cities and counties will use regional resource endowment to develop Nanyao, Liyao Chinese medicine and primary processing industry The pharmaceutical industry will strive to achieve an average annual growth rate of 13% - 15%, and strive to achieve an output value of more than 30 billion yuan by 2020 (during the 13th Five Year Plan period, Hainan will speed up the research and development of South medicine and Liyao's marine drugs Picture source: Baidu picture) recently, the Hainan provincial government issued the guidance on the 13th five year plan for the development of the pharmaceutical industry in Hainan Province, proposing that the pharmaceutical industry in Hainan Province will strive to achieve a production value of more than 30 billion yuan by 2020, which will promote the research and development of South medicine and Liyao's marine drugs It is understood that during the "12th Five Year Plan" period, Hainan Province issued a series of supporting policies to support innovation and R & D, technological transformation, and growth incentives of pharmaceutical enterprises, which promoted the rapid development of the pharmaceutical industry, with an average annual growth rate of 13.5% In 2015, 63 pharmaceutical industry enterprises in the province had an output value of 15.001 billion yuan, 43 Enterprises above Designated Size, 33 enterprises with an annual output value of more than 100 million yuan, realizing a profit and tax of 3.072 billion yuan, a year-on-year increase of 14.5% It is proposed that during the 13th Five Year Plan period, Hainan will speed up the research and development of South medicine and traditional Chinese medicine and primary processing industry by using regional resource endowment The pharmaceutical industry will strive to achieve an average annual growth of 13% - 15%, and strive to achieve an output value of more than 30 billion yuan by 2020